Swastika Investmart's Manipal Health IPO Analysis Featured in Mint

Swastika Investmart's IPO research was featured in Mint, where the publication covered the Manipal Health IPO during its subscription period. The article highlighted the Grey Market Premium (GMP), Day 2 subscription status, and other important issue details while featuring Swastika Investmart's expert review to help investors evaluate the offering.

The coverage further strengthens Swastika Investmart's position as a trusted source for IPO research and market insights across India's leading financial media.

Featured In:

• Mint: Manipal Health IPO: Check latest GMP, day 2 subscription status, and other details - Should you apply or skip?

About Swastika Investmart

Swastika Investmart Limited (BSE: 530585) is one of India's leading public-listed financial services and stockbroking companies. Established in 1992, the company offers comprehensive investment solutions across equities, derivatives, commodities, currency, mutual funds, and wealth management. Through its research-driven approach and technology-enabled platforms, Swastika Investmart empowers investors with actionable market insights, IPO research, and expert advisory services.

Read More About Juniper Manipal Health IPO

• Manipal Health Enterprises IPO: Week's Largest Mainboard 
• Manipal Health Enterprises IPO: Key Numbers And Outlook 
• Manipal Hospitals IPO Valuation And Investor Take 
• Manipal Hospitals IPO: Key Details For Investors